About TuHURA Biosciences
TuHURA Biosciences is a private company based in Tampa, Florida, incorporated in 2023 in Delaware. It has reported $22,899,949 raised in seven offerings on Form D since November 2016.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Dec 11, 2023 | Dec 27, 2023 | $1,665,000of $15.0M target | 8 | $208K | Debt, Options, Securities on exerciseRule 506(c) | Form D ↗ |
| Jun 24, 2022 | Jul 11, 2022 | $9,101,001of $20.0M target | 2 | $4.5M | EquityRule 506(b) | Form D ↗ |
| Oct 29, 2021 | Nov 19, 2021 | $5,100,000target not set | 4 | $1.2M | EquityRule 506(b) | Form D ↗ |
| Oct 28, 2020 | Dec 17, 2020amended Sep 29, 2021 | $3,830,130of $11.0M target | 39 | $98,208 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Jun 20, 2019 | Jul 3, 2019 | $495,000of $15.0M target | 5 | $99,000 | Options, Convertible Promissory NotesRule 506(b) | Form D ↗ |
| Aug 11, 2017 | Aug 21, 2017amended Jan 12, 2018 | $2,708,818of $15.0M target | 40 | $67,720 | EquityRule 506(b) | Form D/A ↗1 earlier filing |
| Not yet | Nov 4, 2016amended Apr 7, 2017 | $0of $5.0M target | 0 | — | EquityRule 506(c) | Form D/A ↗1 earlier filing |
| Total, seven offerings | $22,899,949 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on TuHURA Biosciences's Form D filed Dec 27, 2023.
Earlier filings also listed Peter Staats (director, last listed Jul 2019), Michael Shamblott (executive officer, last listed Jul 2019), Joseph Errico (director, last listed Jul 2019), James McNulty (director, last listed Jul 2019), David Bergmann (director, last listed Jul 2019), Scott Slayton (executive officer, last listed Jan 2018), Grahame Cook (director, last listed Jan 2018) and David Lawman (director, last listed Jan 2018).